Published in Int J Clin Exp Med on November 15, 2015
Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int (2013) 4.37
Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet (2002) 3.90
Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol (1993) 3.83
Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med (2006) 2.22
Magnesium and Dialysis: The Neglected Cation. Am J Kidney Dis (2015) 2.09
Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr (2013) 2.07
Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis (1994) 1.96
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series. QJM (2010) 1.46
Gitelman syndrome: pathophysiological and clinical aspects. QJM (2010) 1.39
Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know. Drugs (2003) 1.34
Hypomagnesaemia due to use of proton pump inhibitors--a review. Neth J Med (2009) 1.33
Serum magnesium and proton-pump inhibitors use: a cross-sectional study. Rev Assoc Med Bras (2013) 1.19
Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res (2007) 1.14
Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors. Gastroenterol Res Pract (2015) 1.01
Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial. Int Urol Nephrol (2008) 1.00
Magnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium. Nephron (1984) 0.99
Uses of proton pump inhibitors and hypomagnesemia. Pharmacoepidemiol Drug Saf (2012) 0.99
Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium. Mol Pharm (2012) 0.98
Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients. Clin Kidney J (2012) 0.98
Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population-Based Cohort Study. Am J Kidney Dis (2015) 0.95
Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study. Am J Kidney Dis (2013) 0.94
Measurement of serum ionized versus total levels of magnesium and calcium in hemodialysis patients. Clin Nephrol (1996) 0.90
Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department. Int J Clin Pract (2014) 0.88
Hypomagnesemia in hemodialysis patients: role of proton pump inhibitors. Am J Nephrol (2014) 0.86
Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation. Hemodial Int (2014) 0.85
Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis (1999) 0.85
Magnesium in chronic kidney disease: unanswered questions. Blood Purif (2011) 0.82
Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users. Am J Ther (2014) 0.79
The determination of whole blood magnesium concentration in uremics on chronic dialysis. Nephron (1981) 0.78